BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29491051)

  • 1. Detection of Distinct Changes in Gene-expression Profiles in Specimens of Tumors and Transition Zones of Tenascin-positive/-negative Head and Neck Squamous Cell Carcinoma.
    Zivicova V; Gal P; Mifkova A; Novak S; Kaltner H; Kolar M; Strnad H; Sachova J; Hradilova M; Chovanec M; Gabius HJ; Smetana K; Fik Z
    Anticancer Res; 2018 Mar; 38(3):1279-1290. PubMed ID: 29491051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the expression of genes between normal tissue and squamous cell carcinomas of head and neck using cancer-related gene cDNA microarray.
    Kainuma K; Katsuno S; Hashimoto S; Oguchi T; Suzuki N; Asamura K; Usami S
    Acta Otolaryngol; 2006 Sep; 126(9):967-74. PubMed ID: 16864496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
    Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
    Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EB-D fibronectin expression in squamous cell carcinoma of the head and neck.
    Mhawech P; Dulguerov P; Assaly M; Ares C; Allal AS
    Oral Oncol; 2005 Jan; 41(1):82-8. PubMed ID: 15598590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
    de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
    Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
    Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
    Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Karpathiou G; Stachowitz ML; Dumollard JM; Gavid M; Froudarakis M; Prades JM; Peoc'h M
    Cancer Genomics Proteomics; 2019; 16(3):155-161. PubMed ID: 31018946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and localization profile of tenascin in squamous cell carcinomas of the head and neck].
    Herold-Mende C; Andl T; Laemmler F; Reisser C; Eichhorn S
    HNO; 1999 Aug; 47(8):723-9. PubMed ID: 10506500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence.
    Zamunér FT; Karia BT; de Oliveira CZ; Santos CR; Carvalho AL; Vettore AL
    Mol Cancer Ther; 2015 Mar; 14(3):828-34. PubMed ID: 25564441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
    Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
    J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.
    Valach J; Fík Z; Strnad H; Chovanec M; Plzák J; Cada Z; Szabo P; Sáchová J; Hroudová M; Urbanová M; Steffl M; Pačes J; Mazánek J; Vlček C; Betka J; Kaltner H; André S; Gabius HJ; Kodet R; Smetana K; Gál P; Kolář M
    Int J Cancer; 2012 Dec; 131(11):2499-508. PubMed ID: 22447203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squamous Cell Carcinoma Antigen-encoding Genes
    Saidak Z; Morisse MC; Chatelain D; Sauzay C; Houessinon A; Guilain N; Soyez M; Chauffert B; Dakpé S; Galmiche A
    Anticancer Res; 2018 Mar; 38(3):1343-1352. PubMed ID: 29491058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.
    Sundquist E; Kauppila JH; Veijola J; Mroueh R; Lehenkari P; Laitinen S; Risteli J; Soini Y; Kosma VM; Sawazaki-Calone I; Macedo CC; Bloigu R; Coletta RD; Salo T
    Br J Cancer; 2017 Feb; 116(5):640-648. PubMed ID: 28095396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Expression Signatures for Head and Neck Cancer Patient Stratification: Are Results Ready for Clinical Application?
    Tonella L; Giannoccaro M; Alfieri S; Canevari S; De Cecco L
    Curr Treat Options Oncol; 2017 May; 18(5):32. PubMed ID: 28474265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma.
    Kikuchi K; Noguchi A; Kasajima R; Miyagi Y; Hoshino D; Koshikawa N; Kubota A; Yokose T; Takano Y
    Tumour Biol; 2015 Sep; 36(10):7865-72. PubMed ID: 25946975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene.
    Tawfik HM; El-Maqsoud NM; Hak BH; El-Sherbiny YM
    Am J Otolaryngol; 2011; 32(6):528-36. PubMed ID: 21353335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tenascin and fibronectin in benign epithelial hyperplastic lesions and squamous carcinoma of the larynx.
    Zidar N; Gale N; Kambic V; Fischinger J
    Anticancer Res; 2001; 21(1A):451-4. PubMed ID: 11299778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.